| scholarly article | Q13442814 |
| P2093 | author name string | Health Quality Ontario | |
| P2860 | cites work | PCI at non-PCI centres: immediate or rescue? | Q57483793 |
| Comparison of Primary Percutaneous Coronary Intervention and Fibrinolytic Therapy in ST-Segment-Elevation Myocardial Infarction | Q57688648 | ||
| Rescue Angioplasty or Repeat Fibrinolysis After Failed Fibrinolytic Therapy for ST-Segment Myocardial Infarction | Q57689096 | ||
| The efficacy and safety of combination glycoprotein IIbIIIa inhibitors and reduced-dose thrombolytic therapy–facilitated percutaneous coronary intervention for ST-elevation myocardial infarction: A meta-analysis of randomized clinical trials | Q57795109 | ||
| Rescue Angioplasty after Failed Thrombolytic Therapy for Acute Myocardial Infarction | Q58009589 | ||
| Stenting versus thrombolysis in acute myocardial infarction trial (STAT) | Q58657447 | ||
| Coronary Stenting plus Platelet Glycoprotein IIb/IIIa Blockade Compared with Tissue Plasminogen Activator in Acute Myocardial Infarction | Q60607085 | ||
| Efficacy of rescue thrombolysis in patients with acute myocardial infarction: preliminary findings | Q60733949 | ||
| Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial | Q67286885 | ||
| Comparison of invasive and conservative strategies after treatment with intravenous tissue plasminogen activator in acute myocardial infarction. Results of the thrombolysis in myocardial infarction (TIMI) phase II trial | Q69367792 | ||
| Thrombolysis with tissue plasminogen activator in acute myocardial infarction: no additional benefit from immediate percutaneous coronary angioplasty | Q69912387 | ||
| SWIFT trial of delayed elective intervention v conservative treatment after thrombolysis with anistreplase in acute myocardial infarction. SWIFT (Should We Intervene Following Thrombolysis?) Trial Study Group | Q70143434 | ||
| Randomized evaluation of coronary angioplasty for early TIMI 2 flow after thrombolytic therapy for the treatment of acute myocardial infarction: a new look at an old study. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group | Q72784934 | ||
| Randomized comparison of rescue angioplasty with conservative management of patients with early failure of thrombolysis for acute anterior myocardial infarction | Q72791723 | ||
| Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE | Q73712341 | ||
| A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction | Q73833294 | ||
| Percutaneous coronary intervention after fibrinolysis: a multiple meta-analyses approach according to the type of strategy | Q79162272 | ||
| Transport for abciximab facilitated primary angioplasty versus on-site thrombolysis with a liberal rescue policy: the randomised Holland Infarction Study (HIS) | Q79756366 | ||
| Comparison of very early treatment with either fibrinolysis or percutaneous coronary intervention facilitated with abciximab with respect to ST recovery and infarct-related artery epicardial flow in patients with acute ST-segment elevation myocardia | Q82994487 | ||
| Longer-term follow-up of patients recruited to the REACT (Rescue Angioplasty Versus Conservative Treatment or Repeat Thrombolysis) trial | Q84160119 | ||
| Primary angioplasty or thrombolysis for acute myocardial infarction? | Q94182707 | ||
| Grading quality of evidence and strength of recommendations | Q24562409 | ||
| Combined angioplasty and pharmacological intervention versus thrombolysis alone in acute myocardial infarction (CAPITAL AMI study) | Q28185717 | ||
| Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial | Q28185728 | ||
| Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomised trial | Q28195154 | ||
| Beneficial effects of immediate stenting after thrombolysis in acute myocardial infarction | Q28199560 | ||
| A randomized trial of rescue angioplasty versus a conservative approach for failed fibrinolysis in ST-segment elevation myocardial infarction: the Middlesbrough Early Revascularization to Limit INfarction (MERLIN) trial | Q28208985 | ||
| A comparison of pharmacologic therapy with/without timely coronary intervention vs. primary percutaneous intervention early after ST-elevation myocardial infarction: the WEST (Which Early ST-elevation myocardial infarction Therapy) study | Q28218869 | ||
| A citywide protocol for primary PCI in ST-segment elevation myocardial infarction | Q28264912 | ||
| Review of immediate angioplasty after fibrinolytic therapy for acute myocardial infarction: insights from the RESCUE I, RESCUE II, and other contemporary clinical experiences | Q33927223 | ||
| Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients | Q34499181 | ||
| Prospective randomised comparison between thrombolysis, rescue PTCA, and primary PTCA in patients with extensive myocardial infarction admitted to a hospital without PTCA facilities: a safety and feasibility study. | Q35565867 | ||
| Assessing the effectiveness of primary angioplasty compared with thrombolysis and its relationship to time delay: a Bayesian evidence synthesis | Q36025772 | ||
| Primary Angioplasty for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence-Based Analysis | Q36070782 | ||
| Rescue thrombolysis: alteplase as adjuvant treatment after streptokinase in acute myocardial infarction | Q36824100 | ||
| Repeat thrombolysis or conservative therapy vs. rescue percutaneous coronary intervention for failed thrombolysis: systematic review and meta-analysis | Q37089415 | ||
| Transferring patients with ST-segment elevation myocardial infarction for mechanical reperfusion: a meta-regression analysis of randomized trials | Q37332642 | ||
| Effectiveness of public report cards for improving the quality of cardiac care: the EFFECT study: a randomized trial | Q38377589 | ||
| Routine early angioplasty after fibrinolysis for acute myocardial infarction | Q39106772 | ||
| Rescue angioplasty during myocardial infarction has a beneficial effect on mortality: a tenable hypothesis | Q41125861 | ||
| Association between timeliness of reperfusion therapy and clinical outcomes in ST-elevation myocardial infarction | Q44073203 | ||
| Efficacy and safety of tenecteplase in combination with the low-molecular-weight heparin enoxaparin or unfractionated heparin in the prehospital setting: the Assessment of the Safety and Efficacy of a New Thrombolytic Regimen (ASSENT)-3 PLUS randomi | Q44504043 | ||
| Facilitated PCI in patients with ST-elevation myocardial infarction | Q46578993 | ||
| Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomised, multicentre trial | Q46749470 | ||
| Transfer with GP IIb/IIIa inhibitor tirofiban for primary percutaneous coronary intervention vs. on-site thrombolysis in patients with ST-elevation myocardial infarction (STEMI): a randomized open-label study for patients admitted to community hospi | Q46989458 | ||
| An early invasive strategy versus ischemia-guided management after fibrinolytic therapy for ST-segment elevation myocardial infarction: a meta-analysis of contemporary randomized controlled trials | Q47372934 | ||
| Routine invasive strategy within 24 hours of thrombolysis versus ischaemia-guided conservative approach for acute myocardial infarction with ST-segment elevation (GRACIA-1): a randomised controlled trial. | Q51612668 | ||
| 1-Year Survival in a Randomized Trial of Facilitated Reperfusion | Q53462233 | ||
| ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction—Executive Summary | Q56986933 | ||
| Comparison of primary angioplasty and pre-hospital fibrinolysis in acute myocardial infarction (CAPTIM) trial: a 5-year follow-up | Q57243419 | ||
| Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study | Q57243545 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | myocardial infarction | Q12152 |
| thrombolysis | Q1931577 | ||
| P304 | page(s) | 1-47 | |
| P577 | publication date | 2010-08-01 | |
| P1433 | published in | Ontario health technology assessment series | Q27722839 |
| P1476 | title | Primary Angioplasty and Thrombolysis for the Treatment of Acute ST-Segment Elevated Myocardial Infarction: An Evidence Update | |
| P478 | volume | 10 |
| Q38162442 | Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011. | cites work | P2860 |
Search more.